Matrix metalloproteinase-2 negatively regulates cardiac secreted phospholipase A2 to modulate inflammation and fever

J Am Heart Assoc. 2015 Mar 27;4(4):e001868. doi: 10.1161/JAHA.115.001868.

Abstract

Background: Matrix metalloproteinase (MMP)-2 deficiency makes humans and mice susceptible to inflammation. Here, we reveal an MMP-2-mediated mechanism that modulates the inflammatory response via secretory phospholipase A2 (sPLA2), a phospholipid hydrolase that releases fatty acids, including precursors of eicosanoids.

Methods and results: Mmp2(-/-) (and, to a lesser extent, Mmp7(-/-) and Mmp9(-/-)) mice had between 10- and 1000-fold elevated sPLA2 activity in plasma and heart, increased eicosanoids and inflammatory markers (both in the liver and heart), and exacerbated lipopolysaccharide-induced fever, all of which were blunted by adenovirus-mediated MMP-2 overexpression and varespladib (pharmacological sPLA2 inhibitor). Moreover, Mmp2 deficiency caused sPLA2-mediated dysregulation of cardiac lipid metabolic gene expression. Compared with liver, kidney, and skeletal muscle, the heart was the single major source of the Ca(2+)-dependent, ≈20-kDa, varespladib-inhibitable sPLA2 that circulates when MMP-2 is deficient. PLA2G5, which is a major cardiac sPLA2 isoform, was proinflammatory when Mmp2 was deficient. Treatment of wild-type (Mmp2(+/+)) mice with doxycycline (to inhibit MMP-2) recapitulated the Mmp2(-/-) phenotype of increased cardiac sPLA2 activity, prostaglandin E2 levels, and inflammatory gene expression. Treatment with either indomethacin (to inhibit cyclooxygenase-dependent eicosanoid production) or varespladib (which inhibited eicosanoid production) triggered acute hypertension in Mmp2(-/-) mice, revealing their reliance on eicosanoids for blood pressure homeostasis.

Conclusions: A heart-centric MMP-2/sPLA2 axis may modulate blood pressure homeostasis, inflammatory and metabolic gene expression, and the severity of fever. This discovery helps researchers to understand the cardiovascular and systemic effects of MMP-2 inhibitors and suggests a disease mechanism for human MMP-2 gene deficiency.

Keywords: PLA2; heart; inflammation; matrix metalloproteinases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Dinoprost / analogs & derivatives
  • Dinoprost / blood
  • Dinoprostone / analysis
  • Fever / physiopathology*
  • Gene Expression Regulation / physiology
  • Inflammation / physiopathology*
  • Matrix Metalloproteinase 2 / physiology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myocardium / chemistry
  • Phospholipases A2, Secretory / analysis
  • Phospholipases A2, Secretory / blood
  • Phospholipases A2, Secretory / physiology*
  • Polymerase Chain Reaction

Substances

  • 8-epi-prostaglandin F2alpha
  • Dinoprost
  • Phospholipases A2, Secretory
  • MMP2 protein, human
  • Matrix Metalloproteinase 2
  • Dinoprostone